Tue, October 6, 2009
Mon, October 5, 2009
Sun, October 4, 2009
Fri, October 2, 2009
Thu, October 1, 2009
Wed, September 30, 2009
Tue, September 29, 2009
Mon, September 28, 2009
Fri, September 25, 2009
Thu, September 24, 2009
Wed, September 23, 2009
Tue, September 22, 2009
Mon, September 21, 2009
Fri, September 18, 2009
Thu, September 17, 2009
Wed, September 16, 2009
Tue, September 15, 2009
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009
Sun, September 6, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Fri, August 28, 2009
Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009
Wed, August 19, 2009
Tue, August 18, 2009
Mon, August 17, 2009
Sun, August 16, 2009
Fri, August 14, 2009
Thu, August 13, 2009
Wed, August 12, 2009
Tue, August 11, 2009

Watson Pharmaceuticals: Watson to Present at the Bank of America Merrill Lynch Global Healthcare Conference


//health-fitness.news-articles.net/content/2009/ .. -merrill-lynch-global-healthcare-conference.html
Published in Health and Fitness on Tuesday, September 8th 2009 at 13:17 GMT by Market Wire   Print publication without navigation


MORRISTOWN, NJ--(Marketwire - September 8, 2009) - Watson Pharmaceuticals, Inc. (NYSE: [ WPI ]), a leading specialty pharmaceutical company, today announced that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Bank of America Merrill Lynch Global Healthcare Conference on Tuesday, September 15, 2009 at 2:30 p.m. (BST) (9:30 a.m. EDT).

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at [ http://ir.watson.com ]. The webcast can also be accessed at the following URL: [ http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=WPI&item_id=2423784 ].

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical. For press release and other company information, visit Watson Pharmaceuticals' Web site at [ http://www.watson.com ].

Forward-Looking Statement

Any statements contained in this press release that refer to future events or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the impact of competitive products and pricing; market acceptance of and continued demand for Watson's products; difficulties or delays in manufacturing; the difficulty of predicting the timing or outcome of FDA or other regulatory agency approvals or actions, if any; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's Quarterly Report on Form 10-Q for the period ended June 30, 2009.


Publication Contributing Sources

Similar Health and Fitness Publications